| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $42K | -90.9% |
| R&D Expense | $2.3M | -28.6% |
| SG&A Expense | $4.5M | -16.0% |
| Operating Income | -$8.5M | +45.4% |
| Net Income | -$9.1M | +46.5% |
| EPS (Basic) | -$10.38 | +69.6% |
| EPS (Diluted) | -$10.38 | +69.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.2M | +202.3% |
| Accounts Receivable | $0 | — |
| Inventory | $453K | +1.3% |
| Current Assets | $3.7M | +141.8% |
| Total Assets | $7.1M | +13.5% |
| Current Liabilities | $2.3M | -60.4% |
| Total Liabilities | $3.8M | -51.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.4M | +11.7% |
| Capital Expenditures | $421 | -100.0% |
| Investing Cash Flow | -$421 | +100.0% |
| Financing Cash Flow | $10.5M | +256.0% |
| Free Cash Flow | -$8.4M | +37.1% |
| Stockholders' Equity |
| $3.4M |
| +321.4% |